Correction to: Multidisciplinary treatment for locally advanced breast cancer with internal mammary lymph node metastasis in an elderly patient

Correction to: International Cancer Conference Journal (2019) 8:1–6 https://doi.org/10.1007/s13691-018-0344-z

In the original publication, in Table 1, the patient 3, 58 years of age, was scheduled to be administered eribulin after gemcitabine as adjuvant therapy. However, the patient was deceased before administration due to sepsis. Eribulin was not administered actually and it needs to be deleted. The corrected Table 1 is given in this Correction.

Table 1 Patient characteristics with internal mammary lymph node metastasis at diagnosis